UPDATE: EpiPen® (Adrenaline) auto-injector availability

UPDATE: EpiPen® (Adrenaline) auto-injector availability

August 24, 2020

Important information regarding EpiPen® and EpiPen® Junior (0.15mg & 0.3mg) as another make of adrenaline auto-injector has been recalled recently

Patients informed to exchange Emerade 500 micrograms adrenaline pens for a different brand

Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.

The recall of Emerade 500 microgram auto-injectors follows the previous recalls of Emerade 150 and 300 microgram auto-injectors. More information on the previous alerts can be found on the following links below. The Emerade pens were recalled in three phases to ensure there would be enough supplies of the alternative pens, EpiPen or Jext, available for patients.

Information is available regarding this switch on the following MHRA website page:

Anaphylactic Guidance regarding dosing is available in the following statement from the Resuscitation Council UK:

EpiPen® (Adrenaline) auto-injector availability update

Mylan have provided the following information sheet regarding availability of 0.3mg and 0.15mg adrenaline auto-injectors:

Further information regarding training resources for EpiPen®

For Healthcare Professionals:

For patients:



Posted in:

More Latest News >

Hepatitis C Training

This presentation delivered jointly by Turning Point and the Hepatitis C Trust provides pharmacy teams with the basic information to...

PCN Pharmacy Leads update

LLR LPC have updated the Pharmacy Lead information for all local PCNs. The update has been added to the following...